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Abstract
Background: IL-21, a member of the common c-chain utilizing family of cytokines, participates in immune and inflammatory
processes. In addition, the cytokine has been linked to autoimmunity in humans and rodents.
Methodology/Principal Findings: To investigate the mechanism whereby IL-21 affects the immune system, we investigated
its role in T cell homeostasis and autoimmunity in both non-autoimmune C57BL/6 and autoimmune NOD mice. Our data
indicate that IL-21R knockout C57BL/6 and NOD mice show increased size of their lymphocyte population and decreased
homeostatic proliferation. In addition, our experimental results demonstrate that IL-21 inhibits T cell survival. These data
suggest that IL-21 acts to limit the size of the T cell pool. Furthermore, our data suggest IL-21 may contribute to the
development of autoimmunity.
Conclusions/Significance: Taken together, our results suggest that IL-21 plays a global role in regulating T cell homeostasis,
promoting the continuous adaptation of the T cell lymphoid space.
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Introduction
The IL-21 cytokine has been implicated in the development and
maintenance of numerous autoimmune and inflammatory diseases
in both animal and human models [1]. IL-21 is produced by
CD4+ T cells and natural killer T cells under autocrine regulation
and functions through the IL-21 receptor (IL-21R) [2,3]. The IL-
21R, which consists of a private IL-21R-a chain and the shared
common c-chain, is widely expressed on T cells, B cells, NK cells,
and dendritic cells in all lymphoid tissues, as well as some non-
immune cells, such as fibroblasts and epithelial cells [4].
IL-21 has been shown to act as a pro-inflammatory Th1-
promoting cytokine. In addition, it has also been shown to inhibit
the differentiation of Th1 cells [5,6,7]. Furthermore, several recent
reports have shown that IL-21 is expressed at much higher levels
in Th17 cells, a distinct Th lineage that is thought to mediate tissue
inflammation [3,8,9,10].
Depending on the specific activation signals received, IL-21 can
either promote or inhibit lymphoid proliferation [7,11]. IL-21 has
been shown to promote apoptosis among NK, B and T cell
populations, although one report demonstrated increased T cell
survival following exposure to IL-21 [7,12,13,14,15]. IL-21 also
promotes T cell effector function, measured by increased CTL
activity and IFNc production [9,13,16].
Previously, we reported that the expression levels of IL-21 and
its receptor were increased in the autoimmune prone NOD mouse
strain compared to mice that contain the corresponding protective
interval from C57BL/6 mice. In addition, we reported that NOD
mice were mildly lymphopenic and contained a higher proportion
of mitotically active T cells in their periphery [17]. In the present
study, we have investigated the role of the IL-21R in T cell
homeostasis using mice on either the non-autoimmune prone
C57BL/6 background or on the autoimmune prone NOD
background. Importantly, our data demonstrate a requirement
for the IL-21R in the regulation of T cell numbers in the periphery
and potentially in the perpetuation of pancreatic autoimmunity.
Results
Increased size of the peripheral T cell pool in IL-21R-
deficient mice
NOD mice have been shown to be mildly lymphopenic [17],
albeit with some controversy [18]. In support, we observed a
decrease in the total number of cells in NOD mice compared to
C57BL/6 mice (Fig. 1A). Since IL-21 has been shown to promote
lymphoid death in some recent studies [1,14,19], we asked
whether IL-21 expression in NOD mice leads to the reduced T cell
numbers observed in these mice. To test this hypothesis we
counted the numbers of cells within the lymphocyte subsets of the
spleens in normal and IL-21R-deficient NOD mice. Our studies
revealed that the total lymphocyte numbers, as well as the
numbers of CD4 and CD8 T cells, were significantly increased in
IL-21R-deficient NOD mice compared to control NOD mice
(Fig. 1B).
To determine whether this is a global effect, we asked if IL-21
affects lymphocyte numbers in the non-autoimmune prone
C57BL/6 strain. Our results demonstrate a significant increase
in the number of total splenocytes and in T cell subsets, as
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Figure 1. Increased cell numbers in IL-21R-deficient mice. (A) Total splenocyte numbers in 6 to 8-week old C57BL/6 mice compared to age-
matched NOD mice (n = 14 mice/group, p = 0.03). (B) Total cell numbers (n = 14 mice/group, p = 0.008), absolute CD4+ T cell numbers (n = 13 mice/
group, p = 0.0002) and absolute CD8+ T cell numbers (n = 14 mice/group, p = 0.003) for the splenocytes of NOD mice, at 6 to 8-weeks of age,
compared to those from age-matched IL-21R KO NOD mice. (C) Total cell numbers (n = 13 mice/group, p = 0.01), absolute CD4+ T cell numbers (n = 12
mice/group, p = 0.02), and absolute CD8+ T cell numbers (n = 19 mice/group, p = 0.04) from the spleens of C57BL/6 mice, average age of 8 weeks, and
IL-21R KO C57BL/6 mice, average age of 9 weeks. (D) Absolute B cell numbers (n = 6 mice/group, p = 0.01) for mice described in C. Data shown are
from three or four independent experiments. Results are presented as mean absolute numbers 6SEM.
doi:10.1371/journal.pone.0003118.g001
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indicated by increased absolute numbers of CD4 and CD8-
positive cells in IL-21R KO C57BL/6 mice compared to age-
matched control C57BL/6 mice (Fig. 1C). In addition, we found
an increase in the absolute numbers of B220-positive cells in IL-
21R KO C57BL/6 mice compared to control mice, confirming
published reports that IL-21 induces B cell apoptosis (Fig. 1D)
[14]. Our results clearly show that IL-21 exposure acts to limit the
numbers of lymphocytes in the periphery in NOD and C57BL/6
mice, suggesting a general role for IL-21 in regulating the size of
the T cell pool.
Reduced proportions of proliferating T cells in IL-21R-
deficient mice
The level of T cell proliferation is regulated in part by the size of
lymphoid compartments, reflecting the innate drive to maintain a
full pool of peripheral lymphocytes [20,21]. We hypothesized that
the overall increase in peripheral T cell numbers in IL-21R-deficient
mice could inhibit T cell proliferation in the periphery. To test this
hypothesis, BrdU was administered in the drinking water of IL-21R-
deficient and control NOD and C57BL/6mice. The proportion and
subset identities of the proliferating T cells within the spleen were
determined by FACS. Since actively dividing cells upregulate CD44
[22], we gated on the CD44hi population of the CD4 and CD8 T cell
subsets. We found that the proportion of these T cells incorporating
BrdU in the periphery was significantly reduced in the absence of the
IL-21R in both the NOD and C57BL/6 strains (Fig. 2A and B).
Homeostatically dividing cells also express high levels of CD62L,
whereas the levels of this antigen are reduced in conventionally
activated T cells [17]. Thus, CD44hiCD62Lhi cells represent
homeostatically proliferating cells and we found a decrease in this
T cell population in the IL-21R deficient NOD mice compared to
NOD mice (Fig. 2C). These results indicate that the proportion of
mitotically active cells that are homeostatically dividing is reduced in
IL-21R-deficient NOD and C57BL/6 mice.
IL-21R KO T cells expand normally upon encounter with
self-antigen
Our results indicate that lack of the IL-21R leads to an increase
in lymphocyte numbers and a decrease in homeostatic T cell
proliferation in the periphery of NOD and C57BL/6 mice. The
reduced proliferation may be explained by an intrinsic defect in
the proliferation of IL-21R-deficient T cells, or by the lack of space
and growth factors in the IL-21R-deficient periphery. To test
whether IL-21R-deficient T cells have a defect in their
proliferative capacity, we backcrossed the IL-21R-deficient
C57BL/6 mouse with the OT1 TCR transgenic strain, which
contains a MHC class1-restricted T cell receptor specific for an
ovalbumin peptide, to derive homozygous IL-21R KO OT1
transgenic mice. Since the ovalbumin antigen is absent from
normal mice, OT1 transgenic mice harbor a monoclonal
population of phenotypically naı̈ve TCR transgenic T cells [23].
We adoptively transferred CFSE-labeled T cells from both IL-21R
KO OT1 and control OT1 mice into recipient Rip-OVA mice, a
strain that expresses ovalbumin in the pancreatic islets. Impor-
tantly, this protocol eliminates critical experimental caveats, since
the genetically identical recipient mice have equivalent numbers of
peripheral lymphocytes. We found that the CFSE-labeled donor
IL-21R KO OT1 T cells from the pancreatic lymph node (PLN)
were able to proliferate significantly more than the control CFSE-
labeled donor OT1 T cells within Rip-OVA recipients (Fig. 3A
and B). This result demonstrates that IL-21R KO cells do not have
an intrinsic defect in proliferation when exposed to antigen.
Similarly, we also observed that both of these populations
proliferated in Rag1-deficient recipients (data not shown), which
do not have any endogenous lymphocytes and provide an empty
environment conducive to homeostatic expansion [24]. The IL-
21R KO cells showed a modest advantage over wild-type controls
(data not shown). Thus, IL-21R deficient T cells show no defect in
T cell expansion, which indicates that the decreased T cell
proliferation observed in Figure 2 arises from the lymphoid
environment of IL-21R KO mice.
Increased T cell survival factors in IL-21R-deficient mice
Some recent studies have demonstrated that unlike the pro-
survival functions of other common c-chain-associated cytokines,
such as IL-7, IL-21 exposure can cause cell death [14,19,25]. We
therefore hypothesized that the increased numbers of lymphocytes
in IL-21R-deficient NOD and C57BL/6 mice might result from
increased T cell survival. In support of this hypothesis, we found
increased levels of the pro-survival protein Bcl-2 in total, activated
(CD44hi) and resting (CD44lo) CD8 T cells in the PLN of IL-21R-
deficient NOD mice and in splenocytes of IL-21R KO C57BL/6
mice, compared to controls for both strains (Fig. 4A and B).
Although the increased Bcl-2 expression in the CD44hi population
of IL-21R KO C57BL/6 mice did not reach the 0.05 level of
significance, the trend is consistent with the other cell populations.
The cytokine milieu in vivo is complex, with competition between
the different c- chain dependent cytokines determining survival or
death. To determine how IL-21 affects cell survival in the presence of
pro-survival cytokines we performed in vitro studies in the presence
and absence of the critical pro-survival cytokine IL-7 [26].
Confirming previous reports, exposure of NOD and OT1
C57BL/6 CD8 T cells to IL-7 resulted in decreased Annexin and
increased Bcl-2 expression compared to cells cultured without this
cytokine [27]. In contrast, treatment with IL-21 failed to inhibit the
expression of Annexin or induce Bcl-2 expression in comparison to
cells cultured in the absence of cytokine (Fig. 5A and B, and data not
shown). Importantly, IL-21 exposure partially blocked the pro-
survival activity of IL-7 in NOD and OT1 C57BL/6 CD8 T cells in
a concentration dependent manner (Fig. 5A and B). Our results
indicate a similar trend with CD4 NOD T cells treated with these
cytokines in vitro (data not shown). Taken together, our data suggest
that IL-21 inhibits the pro-survival function of IL-7, thereby limiting
the size of the lymphoid compartment.
Reduced effector function in IL-21R-deficient NOD mice
IL-21 can promote effector function and Th1 type cytokine
secretion [6,16]. Therefore, we asked whether T cell effector
function was diminished compared to controls by measuring the
frequency of TNF-a or IFN-c-expressing T cells in activated cells
isolated from IL-21R KO and age-matched NOD mice. We found
a reduction in the frequency of CD69- and CD44-expressing CD8
or CD4 T cells spontaneously producing TNFa or IFNc in the
PLN of IL-21R KO NOD mice compared to control NOD
animals (Fig. 6A–D). In addition, we observed reduced absolute
numbers of these cell populations expressing TNF-a or IFN-c in
IL-21R KO NOD mice compared to control NOD animals
(Fig. 6E). Our results demonstrate that the proportion and number
of effector T cells is reduced in IL-21R KO NOD mice compared
to age-matched NOD mice.
The acquisition of T cell effector function promotes islet
destruction during the development of diabetes [28]. Since T cell
effector function was diminished when the IL-21R was absent, we
asked whether IL-21 plays a role in precipitating clinical diabetes in
NOD mice. We tested whether NOD mice lacking the IL-21R are
protected from disease by measuring blood glucose levels in control
and IL-21R KO NOD mice. We found that NOD mice deficient in
IL-21 Limits Lymphoid Space
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Figure 2. Reduced T cell proliferation in IL-21R-deficient mice. Representative histogram plots for individual NOD (thin line) and IL-21R KO
NOD (thick line) mice showing flow cytometric analysis of BrdU incorporation in CD4+CD44hi and CD8+CD44hi populations after 5 days of BrdU
treatment. The data, obtained from analyzing the spleens of 7 to 9-week-old NOD and age-matched IL-21R KO NOD mice, is presented as mean
percentages of BrdU+ cells 6SEM from one experiment with a total of n = 4 mice/group. The experiment, using the same number and age of mice,
was repeated twice with similar results. (B) Representative flow cytometric analyses of splenocytes from individual C57BL/6 (thin line) and IL-21R KO
C57BL/6 (thick line) mice showing BrdU incorporation in CD4+CD44hi and CD8+CD44hi T cells after 5 days of BrdU treatment. Mean percentages of
BrdU+ cells 6SEM are shown from one experiment with a total of n = 4 mice/group with an average age of 10–12 weeks. The experiment was
repeated three times with similar results. For both A and B, the gate on the histogram plots represents isotype control staining. (C) Representative dot
plot showing expression of CD44 and CD62L in the CD4+ population of individual NOD and IL-21R KO NOD mice. Pooled data 6SEM from a total of
n = 8 mice/group, at 7 to 9-weeks of age, from two independent experiments is shown. Gates are based on isotype control staining.
doi:10.1371/journal.pone.0003118.g002
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the IL-21R were completely protected from diabetes (n= 15, 0%
incidence) during the 48-week observation period (Fig. 6F).
Furthermore, pancreatic islet infiltration precedes clinical diabetes,
and is a hallmark of the autoimmune process. To test whether
infiltration of the pancreatic islets was inhibited in the IL-21R KO
NODmice, we performed a comparative histological analysis on the
pancreata from the two groups of mice. We found that the IL-21R-
deficient NOD islets had no detectable inflammation (Fig. 6G). The
absence of diabetes and insulitis suggests that islet autoimmunity is
decreased when IL-21 responses are absent.
Discussion
In this study, we demonstrate that IL-21 has a major impact on
the immune systems of both autoimmune prone and normal mice.
Our experimental results demonstrate that IL-21 negatively
regulates lymphocyte numbers in the periphery, perhaps by
tempering the pro-survival actions of IL-7. Our data demonstrate
that IL-21 plays a central role in lymphocyte homeostasis,
balancing survival and turnover to foster the continuous evolution
of the T cell lymphoid space.
Figure 3. Expansion of IL-21R-deficient T cells upon encounter with self-antigens. CFSE-labeled splenocytes from 6 to 8-week-old (A) OT1
or (B) IL-21R KO OT 1 mice were adoptively transferred into wild-type Rip-OVA recipient mice, with an average age of 8-weeks, for five days. Cells were
then recovered from the pancreatic lymph nodes of recipient mice and analyzed by flow cytometry for CFSE dilution to measure proliferation. A
representative CFSE dilution profile of the indicated Vb5.1+/5.2+ (donor) T cells from individual recipient mouse is shown. The data shown reflects the
mean percentage of CFSEhi and CFSElo T cells 6 SEM for a total of n = 15 mice/group from four independent experiments, p = 0.04. Analysis of cells
before transfer indicated .80% were naı̈ve (CD8+CD44lo, data not shown).
doi:10.1371/journal.pone.0003118.g003
IL-21 Limits Lymphoid Space
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Figure 4. Increased T cell survival factors in IL-21R-deficient mice. (A) Representative histograms showing total Bcl-2 expression in indicated
CD8 populations for individual NOD (dashed line) and IL-21R KO NOD (solid line) mice relative to isotype control staining (gray line). Below, the graph
represents Bcl-2 flow cytometric data 6SEM for one of two independent experiments using n= 4 mice/group. Similar results were found in both
experiments. Pancreatic lymph nodes of NOD mice with an average age of 13-weeks and age-matched IL-21R KO NOD mice were analyzed. (B) Levels
of Bcl-2 expression in the indicated splenocyte subsets for individual C57BL/6 (dashed line) and IL-21R KO C57BL/6 (solid line) mice are shown in
representative histograms relative to isotype control staining (gray line). Below, graphical representations of the percentage of Bcl-2 expression
6SEM pooled from three independent experiments with a total of n = 12 mice/group. 6-8-week-old C57BL/6 mice and aged-matched IL-21R KO
C57BL/6 mice were used.
doi:10.1371/journal.pone.0003118.g004
IL-21 Limits Lymphoid Space
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Lymphocyte numbers are controlled by both pro-survival and
proliferative activities of several key growth factors [29,30]. A
previous study reported no defect in lymphocyte numbers in IL-
21R-deficient mice, which may be explained by the difference in
mouse strains used compared to this study [31]. To analyze the
pro-survival activities of cytokines, we measured the expression of
the apoptotic marker Annexin V, and the pro-survival marker Bcl-
2. We addressed both the in vivo role of IL-21 in T cell survival and
also the function of IL-21 in T cell survival in relation to other
cytokines using an in vitro assay. We observe that IL-21 can reverse
the pro-survival functions of IL-7 in vitro, as documented by
comparing both Annexin V and Bcl-2 expression. Annexin, a
phospholipid-binding protein that binds to membrane phospho-
lipid phosphatidylserine, is released into the external cellular
environment in apoptotic cells, whereas Bcl-2 expression is
regulated by cytokine signaling through the JAK-STAT pathway,
blocking apoptotic signals [32,33]. Taken together, analysis of two
separate markers provides strong evidence that IL-21 opposes the
known pro-survival cytokine IL-7 [34,26].
Since both IL-21 and IL-7 signal through the common c-chain,
it is possible that these factors compete for limiting amounts of this
receptor chain within lymphocytes. In addition, IL-21 has been
shown to activate the JAK-STAT intracellular signaling pathway
distinctly from other common c-chain cytokines, including IL-7
and IL-15, which activate STAT5 [6,35]. Since activation of
STAT5 promotes survival pathways, including the induction of
Bcl-2, the absence of STAT5 activation by IL-21 could be
responsible for its lack of pro-survival effects [33]. Thus, IL-21
may block IL-7 action by preventing the phosphorylation of
STAT5, thereby blocking the induction of Bcl-2. In support of this
idea, B cell death by IL-21 was prevented by over-expression of
Bcl-2 in C57BL/6 mice [12]. Interestingly, STAT1, through
which IL-21 also signals, has been shown to reduce the expression
of Bcl-2 [38].
In addition, IL-21, unlike IL-7, has been shown to activate Stat3
[35]. Stat3 has been associated with apoptosis, where phosphor-
ylated Stat3 activates the p50a and p55a regulatory subunits of PI3
kinase, which reduce the levels of phosphorylated Akt/PKB kinase
and prevent the pro-survival effect of Akt/PKB [36]. In contrast,
IL-7 has been shown to induce the activity of Akt/PKB, which
leads to the phosphorylation and sequestration of the pro-
apoptotic protein BAD. This in turn prevents BAD from
interacting with and inhibiting Bcl-2, thereby allowing the pro-
survival activity of Bcl-2 [37]. Thus, it is possible that IL-21
suppresses the pro-survival effects of IL-7 by inducing STAT3
phosphorylation, which would ultimately prevent the downstream
signaling events necessary for IL-7 mediated survival. IL-21 has
also been shown to activate other pro-apoptotic molecules, such as
BIM and BID [19]. Our observations are consistent with other
reports indicating that IL-21 can induce apoptosis in lymphocytes
[14,19,27,39]. IL-21-mediated induction of T cell survival
reported in a previous study may be due to the concentration of
IL-21 in vitro, where cell viability was enhanced at higher
concentrations of IL-21 [15].
Since cytokines are central in regulating T cell homeostasis, the
actions mediated by IL-7 and IL-21 are physiologically relevant.
The process of T cell homeostasis acts to maintain a constant level
of lymphocytes in the immune system through the regulation of
lymphocyte survival and death. Improper regulation of T cell
homeostatic mechanisms, such as IL-21 inhibition of T cell
survival, can result in decreased numbers of lymphocytes, or
lymphopenia, as observed in both NOD and C57BL/6 mice
compared to IL-21R KO animals of both strains. In NOD mice,
impaired T cell homeostatic mechanisms along with the presence
of islet-reactive T cells contribute to disease progression, as
discussed in greater detail below.
In addition to survival mechanisms, T cell numbers in the
periphery are also regulated by the extent of proliferation that can
be affected by both intrinsic and environmental factors in vivo. All
of the common c-chain binding cytokines can induce aggressive
mitosis of T cells in vitro [29,40]. Supporting this idea, IL-21
induced in vitro proliferation in the presence of cytokines such as
IL-7 and IL-15, and could induce modest amounts of proliferation
Figure 5. IL-21 antagonizes the pro-survival effects of IL-7 in
vitro. Analysis of the effects of IL-21 on T cell survival in the presence or
absence of IL-7. Cells from the spleen and pancreatic lymph nodes of
NOD or OT1 C57BL/6 mice were cultured with IL-7 (1 ng/ml) and/or IL-
21 (1 ng/ml or 10 ng/ml) as described in Materials and Methods.
Graphical representation of Annexin V staining by FACS analysis for
CD8+ T cell populations from (A) NOD and (B) OT1 C57BL/6 mice.
Percentage of Annexin V+ cells cultured in media alone (no cytokine
treatment) was set at 100 and Annexin V+ cells treated with cytokine
are represented as fold change relative to media alone 6SEM.
Percentage of Annexin V+ cells cultured with IL-21 by itself at 10 ng/
ml is similar to cells cultured with IL-21 at 1 ng/ml (data not shown).
The data shown is pooled from two independent experiments.
doi:10.1371/journal.pone.0003118.g005
IL-21 Limits Lymphoid Space
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Figure 6. Decreased T cell effector function in IL-21R-deficient NODmice. Representative dot plots from individual NOD and IL-21R KO NOD
mice showing frequency of (A) TNFa+/CD69+, TNFa+ /CD44+, (B) IFNc+ /CD69+, IFNc+/CD44+ populations in CD8+ T cells and (C) TNFa+/CD69+,
TNFa+/CD44+, (D) IFNc+/CD69+, IFNc+/CD44+ populations in CD4+ T cells. Gates are based on isotype control staining. Graphs represent pooled
flow cytometric data from pancreatic lymph nodes of 11-to-13 week old mice for two independent experiments with a total of n = 8 mice/group.
Results are presented as the mean percentages 6SEM. (E) Percentages of the indicated cell populations from A–D were multiplied by the total
number of cells in the pancreatic lymph nodes for each individual animal to give the absolute numbers for each indicated cell population. Data are
shown as mean absolute numbers 6SEM. (F) Cumulative incidence of diabetes was monitored by measuring blood glucose levels in NOD (close
circles) and IL-21R KO NOD (open squares) mice (n = 15 mice/group) at the indicated ages. (G) Paraffin sections of pancreata from NOD and IL-21R KO
NOD mice stained with H&E. In total, four NOD and four IL-21R KO NOD mice were evaluated, with fifty individual islets examined per strain. The
images shown in these panels were obtained from 2 different mice per strain; the NOD mice were 11 weeks of age; the IL-21R KO NOD mice were 13
weeks of age.
doi:10.1371/journal.pone.0003118.g006
IL-21 Limits Lymphoid Space
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on its own [16,39,40]. Conversely however, another study
demonstrated that IL-21 blocks IL-15 dependent expansion of
activated CD8+ T cells in vitro [13]. It is important to note that in
vitro, T cell proliferation is measured in the absence of the
microenvironmental pressures induced by lymphoid space.
In vivo the steady state proliferation of lymphocytes is dependent
on the size of the peripheral lymphoid pool. Under conditions of low
T cell numbers, the increased availability of growth factors induces
proliferation to increase the size of the lymphoid pool [29]. Since we
observed a significant increase in the number of lymphocytes in the
absence of the IL-21R, the most straightforward explanation for our
results is that proliferation is inhibited due to the increased size of the
T cell pool in the periphery, a situation that would limit the amount
of mitosis. Thus, some of the discrepancy that has arisen regarding
the mitotic actions of IL-21 may be a result of the distinct in vivo and
in vitro approaches utilized, where homeostatic environmental factors
are differentially available.
Although we observed decreased proliferation in IL-21R KO
NOD and C57BL/6 mice, our results do not support a mechanism
whereby IL-21R-deficient T cells are simply inhibited in their
ability to proliferate. Using the OT1 adoptive transfer system we
found that following transfer into normal and immunodeficient
hosts, IL-21R KO T cells are not inhibited in their ability to
proliferate, and are fully capable of both antigen-stimulated and
homeostatically-induced proliferation. Our CFSE dilution results
further suggest that the IL-21R-deficient cells may even have
enhanced proliferative capacity in vivo. This may be mediated by a
reduced intercellular competition for the common c-chain, and
enhanced ligation of IL-2, IL-7 and IL-15, prolonging the
proliferative response. This idea is consistent with the observation
that blocking IL-21 does not inhibit the proliferative response that
occurs upon IL-21 addition, suggesting that IL-21 may act
indirectly to promote proliferation, perhaps through discouraging
ligation of growth promoting cytokines [41]. Our data also support
a previous study demonstrating that IL-21R-/- mice do not show
defects in T cell proliferation [8].
Our data also indicate that when the IL-21R is absent, the
proportion and numbers of effector T cells is diminished. This
result supports previous work where IL-21 has been shown to
induce pro-inflammatory cytokine secretion during rheumatoid
arthritis and increase IFN-c production in a murine model for
experimental autoimmune encephalomyelitis (EAE) [7,42]. The
pro-inflammatory effects of IL-21 may directly arise through its
known activation of the STAT3 pathway, which stimulates the
production of pro-inflammatory cytokines [4,8]. Recent findings
that Th17 cells produce IL-21 further support the connection
between IL-21 and inflammation [3,8,10].
Our previous studies of NOD mice led us to hypothesize that
elevated IL-21 levels contribute to the development of disease by
creating a lymphopenic environment that drives homeostatic
expansion and autoimmunity [17]. In this study, we found that IL-
21 promotes insulitis and diabetes in NOD mice. It is well
established that diabetogenic T cells express high levels of effector
cytokines, such as IFN-c and TNF-a [43,44,45]. The decreased
number of effector T cells we observed in IL-21R deficient mice
underlies the protection against diabetes in the absence of IL-21
signaling. Furthermore, homeostatically expanding cells in NOD
mice have also been shown to rapidly acquire effector function
[17]. In addition to T-cell mediated pathogenesis of type 1
diabetes, B cells have also been shown to contribute to disease
pathogenesis in the form of auto-antibody production or
presentation of self-antigen to T cells thus promoting T-cell
mediated disease [46]. Auto-antibodies to antigens such as
glutamate decarboxylase (GAD) and insulin have been reported
in both NOD mice and type 1 diabetic patients although the direct
pathogenic role of auto-antibodies is still controversial [47].
Recent studies have shown that IL-21 regulates the generation
of T follicular help cells (Tfh) which in turn impact B cell function,
such as in germinal center reactions [48,49]. Germinal center
reactions are present in autoimmune diabetic mice and likely to be
the site where self-reactive auto-antibodies are generated [50]. Tfh
function on B cells could contribute to the protection from disease
we observe in IL-21R KO mice, where decreased Tfh function in
the absence of IL-21R could lead to decreased B cell responses.
Furthermore, it should be noted that it is possible that diabetes
resistance in IL-21R-deficient NOD mice may be attributed to still
unidentified protective alleles in the C57BL/6 genome, as has
been identified in disease-resistant IFNc knockout NOD mice
[51]. Despite this caveat, our studies in NOD and C57BL/6 mice
clearly indicate that IL-21 reduces T cell survival and suggest that
it might promote lymphopenia to drive homeostatic proliferation.
Homeostatically expanding cells in NOD mice probably comprise
islet-reactive T cells with acquired effector function, whereas in
C57BL/6 animals, IL-21 signaling appears to represent a normal
mechanism involved in steady-state maintenance of peripheral T
cell numbers.
Decreased T cell longevity has been causally associated with the
development of autoimmunity. It has been shown that over-
expression of Bcl-2 in both T and B cells leads to protection from
insulitis in NOD mice [52]. There is also clinical support for this
concept, since insulin-dependent diabetes mellitus (IDDM)
patients show significantly reduced Bcl-2 expression in CD3+
and memory CD4+CD45RO+ populations and have higher levels
of spontaneous apoptosis [53]. Furthermore, patients with systemic
lupus erythematosus (SLE) have increased numbers of apoptotic
lymphocytes and macrophages and exhibit decreased cell survival
compared to control subjects [54].
IL-21 has been associated with the development and mainte-
nance of numerous autoimmune and inflammatory diseases in
both animal and human models. For example, polymorphisms of
IL-21 and its receptor were identified in patient samples associated
with Type 1 diabetes (53). Furthermore, increased IL-21R levels
have been reported in patients with rheumatoid arthritis, systemic
sclerosis, and inflammatory bowel disease, including Crohn’s
disease and ulcerative colitis (39, 54–56). Moreover, the BXSB-
Yaa mouse model of SLE expresses elevated circulating levels of
IL-21 (23). Other interesting reports have shown that in vivo
neutralization of IL-21 can lead to decreased rheumatoid arthritis
in rats and lupus development in mice, as well inhibition of matrix
metalloproteinase secretion in inflammatory bowel disease (18, 52,
57). Interestingly, IL-21 activity is increased in Helicobacter pylori
infection, leading to higher production of matrix metalloprotei-
nases MMP2 and MMP9, and MMP2 and MMP9 have been
shown to be upregulated in Type 1 diabetes (58, 59).
There have been various explanations for autoimmunity
resulting from the improper elimination of T cells with a high
affinity for self-antigen. For example, it has been proposed that
autoreactive T cells are part of the normal repertoire, but are
maintained and do not elicit their autoreactive capabilities due to
the presence of T regulatory cells [55]. Indeed, the introduction of
T regulatory cells, characterized as CD4+CD25+, has been shown
to alleviate autoimmune disease in various experimental models,
such as EAE [56]. Interestingly, CD4 T cells are resistant to
suppression by CD4+CD25+ T regulatory cells in the presence of
IL-21 [57]. In addition, IL-21 is able to suppress T regulatory cells
and promote the induction of Th17 cells [8].
Our data provides another aspect critical in the regulation of
autoimmunity by IL-21, which can negatively impact the size of
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the lymphoid compartment. Dysregulation of T cell homeostasis
can result in lymphoproliferative disorders or lymphopeina, both
of which are associated with pathological states (40). Indeed, in
addition to Type 1 diabetes, lymphopenia is characteristic of
several human diseases that also exhibit increased levels of IL-21,
such as rheumatoid arthritis, Crohn’s disease, SLE, and Sjogren’s
syndrome [58]. To compensate for the lack of T cells, proliferation
occurs that favors expansion and activation of auto-reactive T cells
that can lead to autoimmunity [21]. In rheumatoid arthritis,
decreased thymic output leads to increased homeostatic prolifer-
ation that favors T cells of an auto-reactive nature [59].
Conversely, immune activation via homeostatic proliferation is
important for the rejection of tumors and IL-21 administration
may inhibit the progression of metastatic melanoma and renal
carcinoma in clinical protocols [60,61]. Therefore, a complete
understanding of immune homeostatic mechanisms is important
for therapeutic intervention in major diseases affecting humans
worldwide. However, the manifestation of autoimmune disease is
not solely dependent on lymphoid pool size, since other conditions
leading to lymphopenia, such as bone marrow transplantation or
chemotherapy, do not always manifest into autoimmunity [55,58].
Indeed, Krupica et al propose that autoimmunity represents a
two-hit model, where lymphopenia together with other insults,
such as T regulatory cell depletion, promote autoimmunity [62].
Our results support an association between IL-21 expression
and the regulation of T cell numbers in the periphery.
Importantly, IL-21 blockade could represent an important
therapeutic target to control T cell survival and homeostatic
expansion, leading to novel treatment strategies for autoimmune
diseases as well as immunodeficiencies.
Materials and Methods
Mice
All mice were housed at The Scripps Research Institute Animal
Facility (La Jolla, CA). All live animal experiments were approved
by the Institutional Animal Care and Use Committee (IACUC)
and the Animal Research Committee (ARC) and were conducted
in accordance with institutional guidelines for animal care and use.
The IL-21R KO C57BL/6 mice were obtained from Dr. Warren
Leonard (NIH, Bethesda, MD). IL-21R KO C57BL/6 mice were
backcrossed onto the OT1 C57BL/6 transgenic strain to obtain
IL-21R KO OT1 C57BL/6 mice. The presence of the OT1 gene
was confirmed by PCR. We utilized speed congenic backcrossing
and screening techniques to introgress the IL-21R-deficient region
from the C57BL/6 background onto the NOD genetic back-
ground. After 7 generations, these mice were intercrossed to derive
homozygous mutants on the NOD genetic background. We
screened 64 polymorphic markers across the genome (autosomes
only, X and Y chromosomes were selected by breeding), that
included markers for all known regions linked to diabetes
susceptibility Idd loci in the NOD mice, plus an additional 4
markers on Chr. 7 flanking the IL-21R mutation to define the size
of the congenic interval. N7 mice were NOD-derived at all
markers tested across the genome, except for a congenic interval of
less than 5 cM flanking the IL-21R-targeted mutation on Chr. 7.
Immunostaining for Flow Cytometric Analyses
Spleens or pancreatic lymph nodes (PLN) were isolated,
processed and stained for FACS analysis as described previously
[63]. Antibodies were obtained from eBiosciences and BD
Pharmingen. Intracellular staining of Bcl-2, IFNc, and TNFa
(BD Pharmingen) were performed using standard procedures [17].
For intracellular IFNc and TNFa staining, processed cells from
the PLN were stimulated in 96-flat well plates with plate-bound
anti-CD3 (20 mg/ml) and anti-CD28 (10 mg/ml), followed by
treatment with Golgi plug for 5 hours at 37u prior to flow
cytometric staining.
In vitro Cytokine Stimulation
Spleens and PLN from control OT1 or NOD mice were
isolated and processed in RPMI media (Hyclone) supplemented
with penicillin/streptomycin, glutamine (Gibco), Hepes buffer
(Fisher Scientific) and b-mercaptoethanol. 26106 cells were plated
in 48-well plates and cultured for 72 hours at 37u in supplemented
RPMI media. Mouse recombinant interleukin-7 (IL-7), at 1 ng/ml
(eBioscience), and mouse recombinant interleukin-21 (IL-21), at
1 ng/ml or 10 ng/ml (R & D Systems), were added alone or in
combination at the time of culture to the OT1 or NOD cells, after
which the samples were incubated for 72 hours at 37u. After
culture, cells were harvested, stained for Bcl-2 and Annexin V (BD
Pharmingen), and analyzed by FACS as described above.
BrdU Labeling
Groups of mice were fed BrdU (Sigma) at 0.8 mg/mL in their
drinking water for 5 days, with fresh BrdU-containing water
provided daily. Following this, the mice were sacrificed, after
which the splenocytes were isolated and processed as described
previously [17]. After staining with BrdU-specific antibodies and T
cell subset markers following the manufacturer’s protocol (BD
Pharmingen), the T cell subsets incorporating BrdU were
identified and quantitated by FACS.
CFSE Labeling and Adoptive Transfer of T cells
Splenocytes from OT1 or age-matched IL-21R KO OT1 cells
were isolated, processed and labeled with CFSE as described
previously [63]. 0.5–16107 CFSE-labeled cells in 200 mL PBS
were intravenously injected into Rip-OVA recipient mice. After 5
days, the mice were sacrificed and analyzed for CFSE dilution and
cell surface marker staining by FACS. Similarly, CFSE-labeled
OT1 cells were injected into Rag1-deficient mice and analyzed by
FACS 3 days after adoptive transfer.
Diabetes and Immunohistochemistry
Blood glucose levels in NOD and IL-21R KO NOD mice were
measured weekly using Ascensia ELITE blood glucose test strips
(Bayer) and the Ascensia ELITE XL blood glucose meter. Mice
with blood glucose readings above 250 mg/dL for two consecutive
weeks were classified as diabetic. For histological assessment of islet
infiltration, pancreata were fixed in 10% neutral buffered formalin
and embedded in paraffin. Sections (4 mm) from five levels
through the tissue, separated by at least 120 mm, were stained with
H&E.
Statistical analyses
The Student’s t test (unpaired, two-tailed) was used to determine
the level of significance of the data. A p value of ,0.05 was
considered significant. The values corresponding to individual
animals from several independent experiments were combined
and statistically analyzed to determine p values and the standard
error of the mean (SEM).
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